Medisix Therapeutics

Developer of CAR-T therapies to treat cancer and autoimmune diseases

placeSingapore, Singapore, Singapore calendar_todayFounded 2017 groups23 employees language medisixtx.com

Registered entities

Innovation

5 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 58 times.

YearFilings
20191
20201
20211
20221
20243
20254

Investor mix

3 investors on record; lead investors include Lightstone Ventures.

Investor typeCountShare
Venture capital267%
Other / undisclosed133%
Coming soon